TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
HURA on Nasdaq
Shares outstanding
66,600,088
Price per share
$0.57
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
6,452,440
Total reported value
$4,884,328
% of total 13F portfolios
0%
Share change
+331,843
Value change
+$73,342
Number of holders
63
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIGHBRIDGE CAPITAL MANAGEMENT LLC 9.1% $4,424,244 6,060,608 Highbridge Capital Management, LLC 31 Dec 2025
VANGUARD GROUP INC 4.4% -13% $5,628,772 +$87,856 2,269,666 +1.6% The Vanguard Group 30 Sep 2025
CA Patel F&F Investments, LLC 0.9% $1,028,634 447,232 CA Patel F&F Investments, LLC 12 Jun 2025
KP Biotech Group LLC 0.9% $1,028,634 447,232 KP Biotech Group LLC 12 Jun 2025

As of 31 Dec 2025, 63 institutional investors reported holding 6,452,440 shares of TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA). This represents 9.7% of the company’s total 66,600,088 outstanding shares.

Institutional Holders of TuHURA Biosciences, Inc./NV - Common Stock, par value $0.001 per share (HURA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,452,440 $4,884,328 +$73,342 $0.76 63
2025 Q3 6,118,579 $15,175,582 -$534,149 $2.48 67
2025 Q2 6,389,148 $14,249,317 +$6,116,594 $2.23 48
2025 Q1 3,655,045 $11,806,197 +$4,737,391 $3.23 26
2024 Q4 2,159,487 $8,838,702 +$8,791,398 $4.09 26